Patterns of coronary artery disease trends in patients with nephrotic syndrome: A national inpatient study.

Autor: Regis SC; University of Miami/Jackson Memorial Hospital, Miami, FL, USA. Electronic address: scr137@med.miami.edu., Del Castillo-Rix D; University of Miami/Jackson Memorial Hospital, Miami, FL, USA., Colombo R; Jackson Memorial Hospital, Miami, FL, USA.
Jazyk: angličtina
Zdroj: International journal of cardiology [Int J Cardiol] 2024 Sep 01; Vol. 410, pp. 132200. Date of Electronic Publication: 2024 May 24.
DOI: 10.1016/j.ijcard.2024.132200
Abstrakt: Background: Individuals with nephrotic syndrome (NS) are thought to have elevated cardiovascular risk because of a known association with hyperlipidemia. Unfortunately, no studies have compared the cardiovascular risk profiles of individual nephrotic syndromes. This study explores the prevalence and patterns of coronary artery disease (CAD) in patients with different types of NS, which may aid in developing risk reduction strategies.
Methods: This retrospective study queried data from the National Inpatient Sample database spanning 2016-2020 and included patients over the age of 18 years with minimal change disease (MCD), membranous nephropathy (MN), and focal segmental glomerulosclerosis (FSGS). We analyzed the prevalence and trends of hyperlipidemia and CAD in the study population.
Results: Of the 15,025 cohort, there were 3625 (24.1%) MCD, 4160 (27.7%) MN, and 7315 (48.7%) FSGS. Patients with MN were found to be older with a higher prevalence of hyperlipidemia and CAD compared to other groups. The odds of developing CAD when adjusting for confounding factors were increased in FSGS (adjusted odds [aOR] 1.570, 95% CI 1.406-1.753, p < 0.001) while reduced in MCD (aOR 0.671, 95% CI 0.580-0.777, p < 0.001) and MN (aOR 0.782, 95% CI 0.698-0.876, p < 0.001).
Conclusions: The divergent results of the different NS types highlight the need for targeted research to better understand and characterize the distinct cardiovascular risk profiles inherent in each type of nephrotic disease for risk stratification.
Competing Interests: Declaration of competing interest No disclosures/conflicts of interest.
(Copyright © 2024 Elsevier B.V. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: